Raffa Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4K | Buy |
290
+38
| +15% | +$2.06K | ﹤0.01% | 381 |
|
|
2026
Q1 | $15.8K | Buy |
252
+3
| +1% | +$240 | ﹤0.01% | 310 |
|
|
2025
Q4 | $23.7K | Sell |
249
-118
| -32% | -$11.6K | ﹤0.01% | 243 |
|
|
2025
Q3 | $35.8K | Buy |
367
+48
| +15% | +$4.97K | 0.01% | 185 |
|
|
2025
Q2 | $34.3K | Buy |
319
+91
| +40% | +$9.21K | 0.01% | 207 |
|
|
2025
Q1 | $23K | Sell |
228
-118
| -34% | -$11.9K | 0.01% | 209 |
|
|
2024
Q4 | $30.9K | Buy |
346
+27
| +8% | +$2.38K | 0.01% | 185 |
|
|
2024
Q3 | $26.7K | Hold |
319
| – | – | 0.01% | 194 |
|
|
2024
Q2 | $24.6K | Hold |
319
| – | – | 0.01% | 280 |
|
|
2024
Q1 | $21.8K | Hold |
319
| – | – | 0.01% | 293 |
|
|
2023
Q4 | $18.4K | Hold |
319
| – | – | 0.01% | 213 |
|
|
2023
Q3 | $16.8K | Hold |
319
| – | – | 0.01% | 212 |
|
|
2023
Q2 | $17.3K | Hold |
319
| – | – | 0.01% | 216 |
|
|
2023
Q1 | $16K | Hold |
319
| – | – | 0.01% | 237 |
|
|
2022
Q4 | $14.8K | Sell |
319
-12
| -4% | -$520 | 0.01% | 235 |
|
|
2022
Q3 | $12.8K | Buy |
331
+12
| +4% | +$481 | 0.01% | 245 |
|
|
2022
Q2 | $11.9K | Hold |
319
| – | – | 0.01% | 265 |
|
|
2022
Q1 | $14.1K | Hold |
319
| – | – | 0.01% | 250 |
|
|
2021
Q4 | $13.6K | Buy |
319
+85
| +36% | +$3.57K | ﹤0.01% | 260 |
|
|
2021
Q3 | $10.2K | Buy |
234
+6
| +3% | +$265 | ﹤0.01% | 258 |
|
|
2021
Q2 | $9.75K | Hold |
228
| – | – | ﹤0.01% | 268 |
|
|
2021
Q1 | $8.81K | Buy |
228
+22
| +11% | +$833 | ﹤0.01% | 293 |
|
|
2020
Q4 | $7.41K | Hold |
206
| – | – | ﹤0.01% | 292 |
|
|
2020
Q3 | $7.87K | Buy |
206
+19
| +10% | +$732 | ﹤0.01% | 263 |
|
|
2020
Q2 | $6.57K | Buy |
187
+37
| +25% | +$1.33K | ﹤0.01% | 272 |
|
|
2020
Q1 | $4.89K | Buy |
150
+56
| +60% | +$2.19K | ﹤0.01% | 284 |
|
|
2019
Q4 | $4.25K | Hold |
94
| – | – | ﹤0.01% | 289 |
|
|
2019
Q3 | $3.83K | Buy |
+94
| New | +$3.98K | ﹤0.01% | 299 |
|
|
2019
Q2 | – | Sell |
-94
| Closed | -$3.61K | – | 830 |
|
|
2019
Q1 | $3.61K | Hold |
94
| – | – | ﹤0.01% | 271 |
|
|
2018
Q4 | $3.32K | Hold |
94
| – | – | ﹤0.01% | 285 |
|
|
2018
Q3 | $3.62K | Hold |
94
| – | – | ﹤0.01% | 293 |
|
|
2018
Q2 | $3.07K | Hold |
94
| – | – | ﹤0.01% | 303 |
|
|
2018
Q1 | $2.57K | Buy |
+94
| New | +$2.56K | ﹤0.01% | 312 |
|
|
2017
Q1 | – | Sell |
-39
| Closed | -$844 | – | 447 |
|
|
2016
Q4 | $844 | Hold |
39
| – | – | ﹤0.01% | 492 |
|
|
2016
Q3 | $928 | Hold |
39
| – | – | ﹤0.01% | 440 |
|
|
2016
Q2 | $911 | Hold |
39
| – | – | ﹤0.01% | 431 |
|
|
2016
Q1 | $734 | Hold |
39
| – | – | ﹤0.01% | 511 |
|
|
2015
Q4 | $719 | Hold |
39
| – | – | ﹤0.01% | 505 |
|
|
2015
Q3 | $640 | Hold |
39
| – | – | ﹤0.01% | 551 |
|
|
2015
Q2 | $690 | Hold |
39
| – | – | ﹤0.01% | 524 |
|
|
2015
Q1 | $692 | Hold |
39
| – | – | ﹤0.01% | 532 |
|
|
2014
Q4 | $517 | Hold |
39
| – | – | ﹤0.01% | 664 |
|
|
2014
Q3 | $461 | Buy |
+39
| New | +$491 | ﹤0.01% | 687 |
|
|
2014
Q1 | – | Sell |
-39
| Closed | -$517 | – | 339 |
|
|
2013
Q4 | $517 | Buy |
+39
| New | +$461 | ﹤0.01% | 664 |
|
Other funds holding BSX
Raffa Wealth Management's BSX Position: Q2 2026 in Review
Raffa Wealth Management increased its Boston Scientific (BSX) stake by 15% in Q2 2026, buying an estimated $2.06K and bringing the position to 290 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #381.
Raffa Wealth Management first reported a position in BSX in Q4 2013 and has held it in 44 quarters since. The position peaked at $35.8K in Q3 2025. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Raffa Wealth Management held 290 shares of Boston Scientific worth $12.4K as of Q2 2026.
- Raffa Wealth Management bought 38 Boston Scientific shares in Q2 2026, an estimated $2.06K.
- Boston Scientific made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #381 holding.
- Raffa Wealth Management first reported a position in Boston Scientific in Q4 2013 and has held it in 44 quarters since.
- Raffa Wealth Management's Boston Scientific position peaked at $35.8K in Q3 2025.
- 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.